AATS Evaluation and Management of N2+ Non-Small Cell Lung Cancer 2026 Consensus Document

Clinical Guideline InSights · May 19, 2026 · 3m

The 2026 Evaluation and Management of N2+ Non-Small Cell Lung Cancer consensus document, highlighting key consensus statements on staging, use of chemoimmunotherapy, resectability, and more.

Evaluation and Management of N2+ Non-Small Cell Lung Cancer

American Association for Thoracic Surgery

May 2, 2026

Guideline Summary: https://www.guidelinecentral.com/guideline/5216039/

Full-Text: https://www.jtcvs.org/article/S0022-5223(26)00899-8/pdf